Adjuvant chemotherapy for non-small cell lung cancer.
Journal Article (Journal Article;Review)
The survival after complete resection for non-small cell lung cancer (NSCLC) is unsatisfactory. Until recently, the use of adjuvant therapy after resection for early stage disease has not been proven to improve survival. However, the efficacy of adjuvant therapy has been demonstrated in phase III prospective randomized trials. The appropriate use of adjuvant therapy, including biologic therapy, is currently under investigation.
- D'Amico, TA
Volume / Issue
- 17 / 3
Start / End Page
- 195 - 198
International Standard Serial Number (ISSN)
Digital Object Identifier (DOI)
- United States